[Drugs affecting apoptosis in the immune system]
1Altalános Orvostudomány Kar, II. sz. Belgyógyászati Klinika, Semmelweis Egyetem, Budapest.
Orvosi Hetilap
|February 7, 2002
Summary
Pharmacological targeting of apoptosis, programmed cell death, offers potential for treating autoimmune diseases. However, current agents lack selectivity, causing side effects and complex outcomes, necessitating further research for safer clinical use.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Context:
- Apoptosis plays a crucial role in immune system regulation, both in normal physiological processes and in pathological conditions.
- Understanding and manipulating apoptosis is a key strategy for managing autoimmune diseases.
Purpose:
- To review key agents that influence apoptosis within the immune system from a clinical perspective.
- To highlight the challenges and potential of pharmacological interventions targeting apoptosis in autoimmune diseases.
Summary:
- Numerous compounds can affect apoptosis, but their mechanisms are often poorly understood.
- Many agents lack specificity, impacting overall organism function and leading to significant side effects.
- The same compound can induce or inhibit apoptosis depending on experimental context and concentration.
Impact:
- Advances in understanding apoptosis mechanisms could lead to safer and more effective clinical applications.
- Targeting apoptosis selectively presents a promising avenue for novel autoimmune disease therapies.
- Further research is essential to overcome current limitations and realize the therapeutic potential of apoptosis modulation.
More Related Videos
Related Concept Videos
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...